AI Analysis

How does ANNX.ST make money? Does ANNX.ST have pricing power? What's the Earnings Whisper? Will ANNX.ST profit more as the business scales? What is ANNX.ST's management track record? Is ANNX.ST's current price justified?

Annexin Pharmaceuticals AB

SEK 6.64 -$13.26 (-66.63%)

STO · 30 Oct 2026 10:26 UTC

Previous Close

SEK 6.70

Day Range

SEK 6.52SEK 6.80

Year Range

SEK 6.52SEK 27.80

Market Cap

57.89M

AVG Volume

8.73K

Trailing/Forward PE

-1.51/-

PEG ratio

0.03

Dividend Yield

Next Earnings Date

Primary Exchange

Stockholm Stock Exchange

Net Income (SEK) · Q

ANNX.ST Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q3	-9.49M
26 Q2	-11.56M
26 Q1	-10.52M
25 Q4	-10.52M
25 Q3	-9.9M
25 Q2	-8.5M
25 Q1	-7.97M
24 Q4	-12.35M
24 Q3	-10.93M
24 Q2	-14.51M

Operating Income (SEK) · Q

ANNX.ST Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q3	-9.5M
26 Q2	-11.43M
26 Q1	-10.55M
25 Q4	-10.26M
25 Q3	-10.05M
25 Q2	-8.58M
25 Q1	-7.97M
24 Q4	-12.63M
24 Q3	-10.93M
24 Q2	-14.46M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (SEK) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Annexin Pharmaceuticals AB

Earnings: ANNX.ST

Video analysis: ANNX.ST

News: ANNX.ST

Similar companies